Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
The Journal of Infectious Diseases
|
February 1, 1991
The human humoral immune response to Salmonella typhi Ty21a
B D Forrest, J T LaBrooy, L Beyer, et al.
Immunology and Cell Biology
|
June 1, 1990
Lymphocyte activation as measured by interleukin-2 receptor expression to gluten fraction 111 in coeliac disease
I A Penttila, C E Gibson, B D Forrest, et al.
Immunology
|
February 1, 1990
The serum polymeric IgA antibody response to typhoid vaccination; its relationship to the intestinal IgA response
R C Bartholomeusz, B D Forrest, J T Labrooy, et al.
The Journal of Clinical Investigation
|
March 1, 1990
Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans
J G Morris, T Takeda, B D Tall, et al.
Asian Pacific Journal of Allergy and Immunology
|
June 1, 1997
International clinical trials of HIV vaccines: II. phase I trial of an HIV-1 synthetic peptide vaccine evaluating an accelerated immunization schedule in Yunnan, China
D Li, B D Forrest, Z Li, et al.
AIDS Research and Human Retroviruses
|
January 1, 1997
Safety and immunogenicity of UBI HIV-1MN octameric V3 peptide vaccine administered by subcutaneous injection
A D Kelleher, S Emery, P Cunningham, et al.
Asian Pacific Journal of Allergy and Immunology
|
March 1, 1997
International clinical trials of HIV vaccines: I. Phase I trial of an HIV-1 synthetic peptide vaccine in Bangkok, Thailand
P Phanuphak, S Teeratakulpixarn, S Sarangbin, et al.
The Journal of Infectious Diseases
|
January 1, 1997
Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine
A Leach, P A Twumasi, S Kumah, et al.
The Journal of Infectious Diseases
|
February 1, 1996
A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group
G J Gorse, M C Keefer, R B Belshe, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
The Journal of Infectious Diseases
|
February 1, 1991
The human humoral immune response to Salmonella typhi Ty21a
B D Forrest, J T LaBrooy, L Beyer, et al.
Immunology and Cell Biology
|
June 1, 1990
Lymphocyte activation as measured by interleukin-2 receptor expression to gluten fraction 111 in coeliac disease
I A Penttila, C E Gibson, B D Forrest, et al.
Immunology
|
February 1, 1990
The serum polymeric IgA antibody response to typhoid vaccination; its relationship to the intestinal IgA response
R C Bartholomeusz, B D Forrest, J T Labrooy, et al.
The Journal of Clinical Investigation
|
March 1, 1990
Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans
J G Morris, T Takeda, B D Tall, et al.
Asian Pacific Journal of Allergy and Immunology
|
June 1, 1997
International clinical trials of HIV vaccines: II. phase I trial of an HIV-1 synthetic peptide vaccine evaluating an accelerated immunization schedule in Yunnan, China
D Li, B D Forrest, Z Li, et al.
AIDS Research and Human Retroviruses
|
January 1, 1997
Safety and immunogenicity of UBI HIV-1MN octameric V3 peptide vaccine administered by subcutaneous injection
A D Kelleher, S Emery, P Cunningham, et al.
Asian Pacific Journal of Allergy and Immunology
|
March 1, 1997
International clinical trials of HIV vaccines: I. Phase I trial of an HIV-1 synthetic peptide vaccine in Bangkok, Thailand
P Phanuphak, S Teeratakulpixarn, S Sarangbin, et al.
The Journal of Infectious Diseases
|
January 1, 1997
Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine
A Leach, P A Twumasi, S Kumah, et al.
The Journal of Infectious Diseases
|
February 1, 1996
A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group
G J Gorse, M C Keefer, R B Belshe, et al.
Page
of 2